Bleeding Risk and Antithrombotic Strategy in Patients with Sinus Rhythm Heart Failure with Reduced Ejection Fraction Treated with Warfarin or Aspirin

We sought to assess the performance of existing bleeding risk scores, such as HAS-BLED or OBRI, in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin. We calculated HAS-BLED and OBRI risk scores for 2,305 patients with HFrEF in SR...

詳細記述

保存先:
書誌詳細
出版年:Am J Cardiol
主要な著者: Ye, Siqin, Cheng, Bin, Lip, Gregory Y. H., Buchsbaum, Richard, Sacco, Ralph L., Levin, Bruce, Di Tullio, Marco R., Qian, Min, Mann, Douglas L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Mohr, J.P., Graham, Susan, Labovitz, Arthur J., Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Thompson, John L.P., Homma, Shunichi
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554775/
https://ncbi.nlm.nih.gov/pubmed/26189039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2015.06.016
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料